ALEXIS THAM
ARCADIA, CA NPI 1043979461
Browse related groups: CA Incyte Corporation All categories
General Payments — all program years on this page
$623.06
- Category: General Payments
- Program years: PY2022–2024
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $385.85 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.86 | 7 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $189.65 | 3 |
| GENZYME CORPORATION | $93.42 | 2 |
| Dermavant Sciences, Inc. | $57.38 | 1 |
| ABBVIE INC. | $29.40 | 1 |
| LEO Pharma Inc. | $16.00 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1113842261 | ABBVIE INC. | $29.40 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128018608 | Dermavant Sciences, Inc. | $57.38 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140002241 | GENZYME CORPORATION | $46.63 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140002261 | GENZYME CORPORATION | $46.79 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141211663 | Incyte Corporation | $29.93 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141252808 | Incyte Corporation | $59.73 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141282865 | Incyte Corporation | $99.99 | 03/07/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1152691077 | LEO Pharma Inc. | $16.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.